L & S Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
3,146
-158
| -5% | -$70.3K | 0.14% | 151 |
|
|
2025
Q1 | $1.6M | Buy |
3,304
+493
| +18% | +$239K | 0.2% | 131 |
|
|
2024
Q4 | $1.13M | Sell |
2,811
-406
| -13% | -$163K | 0.12% | 169 |
|
|
2024
Q3 | $1.5M | Sell |
3,217
-265
| -8% | -$123K | 0.16% | 153 |
|
|
2024
Q2 | $1.63M | Buy |
3,482
+173
| +5% | +$81.1K | 0.19% | 143 |
|
|
2024
Q1 | $1.38M | Buy |
3,309
+122
| +4% | +$51K | 0.16% | 161 |
|
|
2023
Q4 | $1.3M | Sell |
3,187
-1,091
| -26% | -$444K | 0.16% | 148 |
|
|
2023
Q3 | $1.49M | Buy |
4,278
+947
| +28% | +$329K | 0.21% | 123 |
|
|
2023
Q2 | $1.17M | Buy |
3,331
+772
| +30% | +$272K | 0.16% | 138 |
|
|
2023
Q1 | $806K | Sell |
2,559
-614
| -19% | -$193K | 0.11% | 174 |
|
|
2022
Q4 | $916K | Buy |
+3,173
| New | +$916K | 0.17% | 137 |
|
|
2020
Q4 | – | Sell |
-4,535
| Closed | -$1.23M | – | 368 |
|
|
2020
Q3 | $1.23M | Buy |
4,535
+586
| +15% | +$159K | 0.17% | 171 |
|
|
2020
Q2 | $1.15M | Sell |
3,949
-232
| -6% | -$67.3K | 0.17% | 151 |
|
|
2020
Q1 | $995K | Buy |
4,181
+1,381
| +49% | +$329K | 0.19% | 120 |
|
|
2019
Q4 | $613K | Buy |
+2,800
| New | +$613K | 0.08% | 194 |
|